Immuno oncology News and Research

RSS

Advancements in the use of AI in Oncology explored at Cleveland

Artificial Intelligence, machine learning and smart computing are all rapidly transforming the global health and medical landscape, including at Case Western Reserve University and among its health-care partners in Northeast Ohio and beyond.

14 Oct 2019

Spatial Gene Expression Profiling of Neurological Disorders

In this interview, Cedric Uytingco discusses the key benefits of being able to visualize gene expression patterns in neurological samples.

From 10x Genomics, Inc. 7 Oct 2019

Cytek Biosciences hits flow cytometry milestone: 40 color analysis from a single sample

Flow cytometry’s next chapter is here. Opening the door to deeper immunological insights, Cytek Biosciences Inc., a leading provider of flow cytometry instrumentation, today announced that it has successfully developed and demonstrated a high-quality 40-color panel from a single sample using the Cytek® Aurora advanced flow cytometry system.

From Cytek Biosciences 5 Oct 2019

Cytek Biosciences' flow cytometry system achieves 40 color analysis from a single sample

From Cytek Biosciences 4 Oct 2019

'Protein mapping' approach reveals why metastatic melanoma patients do not respond to immunotherapy

Tel Aviv University and Sheba Medical Center researchers say they have discovered why more than half of patients with metastatic melanoma do not respond to immunotherapy cancer treatments.

10 Sep 2019

Collaborative project aims to discover novel regulators of immune responses

Harvard University and Merck are launching a collaboration that will provide significant research funding for up to four years to support immuno-oncology research led by Arlene Sharpe, MD, PhD, at Harvard Medical School.

13 Aug 2019

New research explains why some cancers don't respond to immunotherapy

New research has uncovered a mechanism thought to explain why some cancers don't respond to a widely used form of immunotherapy called "checkpoint inhibitors" or anti-PD-1.

6 Aug 2019

Pelotonia Institute for Immuno-Oncology launched at Ohio State to fight cancer at all levels

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute today announced formation of the Pelotonia Institute for Immuno-Oncology, a comprehensive bench-to-bedside research initiative focused on harnessing the body's immune system to fight cancer at all levels-;from prevention to treatment and survivorship.

27 Jul 2019

Special blood test may predict relapse risk for breast cancer patients

A special blood test may one day predict if a newly diagnosed breast cancer patient will likely relapse years later, a City of Hope study suggests.

9 Jul 2019

Cytek Biosciences unveils advanced five-laser flow cytometer

When five lasers and more than 30 colors combine, new breakthroughs and scientific discoveries take shape.

From Cytek Biosciences 20 Jun 2019

Quanterix announces $50,000 in grants to support promising oncology research

Quanterix announced a call for proposals for a new Accelerator Grant Program.

From Quanterix 16 May 2019

7th Annual PREDiCT: Tumor Models Boston summit will help scientists to improve cancer research

The 7th Annual PREDiCT: Tumor Models Boston summit will be held on July 16 – 18 2019 in Boston, MA. For its anticipated return, Tumor Models Boston rebrands alongside its sister events in San Francisco, London and Asia to become PREDiCT: Tumor Models Boston as part of the PREDiCT: Tumor Models Series.

From PREDiCT 24 Apr 2019

New class of drugs could help treat patients diagnosed with ovarian cancer

A team of researchers across The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.

19 Mar 2019

New analysis highlights increasing focus of early-stage clinical trials on rare cancers

The proportion of early-stage drug trials tackling the biggest cancer killers has declined sharply since the early 1990s as less common tumor types receive increasing attention, according to new research to be presented during the International Congress on Targeted Anticancer Therapies 2019, taking place from today to 27 February in Paris, France.

25 Feb 2019

Immune checkpoint molecule protects against future development of cancer

A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.

15 Feb 2019

MD Anderson Cancer Center collaborates with Dragonfly for new immunotherapy drug clinical trials

The University of Texas MD Anderson Cancer Center and Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly's TriNKET™ immunotherapy drug candidates to patients in clinical trials beginning in 2019.

16 Jan 2019

Quanterix extends oncology footprint with accelerated launch of next gen SP-X platform and CorPlex validated 10-Plex

Quanterix announce launch of its Simoa SP-X Imaging and Detection System, 10-Plex Simoa CorPlex Cytokine Panel, and broad menu of additional multiplex panels.

From Quanterix 10 Jan 2019

MD Anderson Cancer Center and Nanobiotix collaborate to expand clinical development of NBTXR3

The University of Texas MD Anderson Cancer Center and Nanobiotix today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers, with the first trials to be launched in 2019.

7 Jan 2019

Cytek marks major milestone by shipping its 100th advanced flow cytometry system

Cytek Biosciences Inc., the preeminent provider of innovative flow cytometry solutions, has marked a significant milestone: the company has shipped 100 of its advanced flow cytometry systems.

From Cytek Biosciences 7 Jan 2019

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

The University of Texas MD Anderson Cancer Center and 4D pharma today announced a strategic collaboration to evaluate 4D's live biotherapeutic oncology pipeline across a range of cancer settings.